<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CFCC5F4C-4471-49F0-9300-C30C2FDC6A9D"><gtr:id>CFCC5F4C-4471-49F0-9300-C30C2FDC6A9D</gtr:id><gtr:name>Bernhard Nocht Inst. for Trop. Medicine</gtr:name><gtr:address><gtr:line1>Bernhard Nocht Inst. for Trop. Medicine</gtr:line1><gtr:line2>Bernhard Nocht Stra?e 74</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F345476-DAED-4C07-8DC6-274842A1C37F"><gtr:id>6F345476-DAED-4C07-8DC6-274842A1C37F</gtr:id><gtr:name>National Centre for Research and Training on Malaria (CNRFP)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CFCC5F4C-4471-49F0-9300-C30C2FDC6A9D"><gtr:id>CFCC5F4C-4471-49F0-9300-C30C2FDC6A9D</gtr:id><gtr:name>Bernhard Nocht Inst. for Trop. Medicine</gtr:name><gtr:address><gtr:line1>Bernhard Nocht Inst. for Trop. Medicine</gtr:line1><gtr:line2>Bernhard Nocht Stra?e 74</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F345476-DAED-4C07-8DC6-274842A1C37F"><gtr:id>6F345476-DAED-4C07-8DC6-274842A1C37F</gtr:id><gtr:name>National Centre for Research and Training on Malaria (CNRFP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BA4590AE-07B8-4B54-9DB9-836F8F6853CF"><gtr:id>BA4590AE-07B8-4B54-9DB9-836F8F6853CF</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Bejon</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002624"><gtr:id>DC4F28F5-587E-4D15-8C77-F1E5901D4534</gtr:id><gtr:title>Defining hotspots of malaria transmission</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1002624</gtr:grantReference><gtr:abstractText>Malaria transmission is patchy at a local level, with hotspots of intense transmission. This hinders control measures, but also means that targeting additional interventions on hotspots will be highly effective. At present, we do not know how best to detect these hotspots, or how to apply the interventions available. For example, we need to know how much transmission in the surrounding area results from the hotspot, and how focal the point source is.
I will analyse 19 years of historical data on malaria from coastal Kenya, supplemented by data from the Gambia in West Africa, to determine the spatial patterns of hotspots and how they might be detected. I will extend my findings by collaborations with investigators collecting spatial data on malaria cases in Gambia, Indonesia and elsewhere in Africa. 
In collaboration with Dominic Kwiatkowski in the Wellcome Trust Sanger Institute, I will conduct detailed genotyping studies to assign a bar-code to malaria parasites. This will allow me to distinguish the recent origin of malaria parasites isolated in the field, in order to inform the design of targeted interventions against hotspots.</gtr:abstractText><gtr:technicalSummary>Malaria transmission is spatially heterogeneous, and groups of homesteads that form hotspots or clusters of transmission can be identified. The presence of these hotspots makes malaria control measures less effective than they might be. However, adding targeted interventions to interrupt these hotspots will be highly effective. At present, we lack detailed epidemiological descriptions of the properties of hotspots and the ways in which they might be identified by malaria control programmes. Furthermore, in order to rationally design targeted interventions, we need to understand their transmission dynamics. For example, we need to know how much transmission in the surrounding area results from the hotspot, and how focal the point source is.
I will analyse 19 years of historical data on severe malaria, mild malaria and asymptomatic infection in Kilifi, Kenya. I will use datasets from cohorts under active surveillance in the field, and passive dispensary and hospital level surveillance, to describe the spatial and temporal limits of individual clusters of transmission, and the epidemiological markers of them. I will obtain external validation of my findings by collaborations with investigators collecting spatial data on malaria cases in Africa, including the Gambia and Indonesia.
In collaboration with Dominic Kwiatkowski in the Wellcome Trust Sanger Institute, I will conduct detailed genotyping studies to assign a bar-code to parasites. High resolution spatial and genotyping data will be combined to accurately identify transmission in and around hotspots, in order to predict the likely outcomes of intervening in hotspots. I will use a descriptive statistical approach for my primary analysis, but will also collaborate with Gil McVean (Oxford University), Dave Smith (Florida University) and Azra Ghani (Imperial College) to conduct post hoc analyses of the population genetic structure, potential indirect effects of interventions and Bayesian approaches to cluster determination, respectively.</gtr:technicalSummary><gtr:fund><gtr:end>2017-06-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1192884</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Multi-centre hotspots</gtr:description><gtr:id>4A045801-4782-4E60-A2FD-9E0ACD3606BE</gtr:id><gtr:impact>A pooled analysis of data has been completed and submitted for publication.</gtr:impact><gtr:outcomeId>58b80f72505156.04123765-4</gtr:outcomeId><gtr:partnerContribution>Sharing of data in order to support a pooled analysis of hotspots in multiple datasets. Submitted for publication.</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bernhard Nocht Institute for Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Multi-centre hotspots</gtr:description><gtr:id>EFF09F52-875D-4A3E-BE0F-E8DB0D38FD97</gtr:id><gtr:impact>A pooled analysis of data has been completed and submitted for publication.</gtr:impact><gtr:outcomeId>58b80f72505156.04123765-3</gtr:outcomeId><gtr:partnerContribution>Sharing of data in order to support a pooled analysis of hotspots in multiple datasets. Submitted for publication.</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Centre for Research and Training on Malaria (CNRFP)</gtr:collaboratingOrganisation><gtr:country>Burkina Faso</gtr:country><gtr:description>Multi-centre hotspots</gtr:description><gtr:id>6E091702-F776-4100-9208-B42D38C7FA11</gtr:id><gtr:impact>A pooled analysis of data has been completed and submitted for publication.</gtr:impact><gtr:outcomeId>58b80f72505156.04123765-2</gtr:outcomeId><gtr:partnerContribution>Sharing of data in order to support a pooled analysis of hotspots in multiple datasets. Submitted for publication.</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Genomics and Global Health, WTCHG and WTSI</gtr:department><gtr:description>Kwiatkowski Group</gtr:description><gtr:id>C658C55F-6E52-45F3-9171-C1889A53435C</gtr:id><gtr:impact>Analyses and work still in progress.</gtr:impact><gtr:outcomeId>EpujxfdKH1Y-1</gtr:outcomeId><gtr:partnerContribution>Provision of data from previously analysed samples in Ghana. 
Laboratory resources and bio-informatics support to process samples from Kenya.</gtr:partnerContribution><gtr:piContribution>I will use sequence data from Ghana for spatial analyses.
I will provide samples from previous field work in Kenya for genotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kenyan Institute for Medical Research (KEMRI)</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI CGMRC Programme</gtr:department><gtr:description>Dave Smith, Janet Midega</gtr:description><gtr:id>B15F2723-37D3-4A70-9DC3-3684E3635F7A</gtr:id><gtr:impact>Publication in Nat. Comms, 2012, Midega et al.
Ongoing field work for follow up studies.</gtr:impact><gtr:outcomeId>PXcbrENmjXo-2</gtr:outcomeId><gtr:partnerContribution>Analytical support (Dave Smith) and entomological studies (Janet Midega)</gtr:partnerContribution><gtr:piContribution>Analysis of spatial field entomology data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>Multi-centre hotspots</gtr:description><gtr:id>787C520B-AF08-4A97-9F49-D8C4FADE259A</gtr:id><gtr:impact>A pooled analysis of data has been completed and submitted for publication.</gtr:impact><gtr:outcomeId>58b80f72505156.04123765-1</gtr:outcomeId><gtr:partnerContribution>Sharing of data in order to support a pooled analysis of hotspots in multiple datasets. Submitted for publication.</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Epidemiology</gtr:department><gtr:description>Dave Smith, Janet Midega</gtr:description><gtr:id>4E9FEAA7-844E-4E6A-B8DD-71C5F4C09277</gtr:id><gtr:impact>Publication in Nat. Comms, 2012, Midega et al.
Ongoing field work for follow up studies.</gtr:impact><gtr:outcomeId>PXcbrENmjXo-1</gtr:outcomeId><gtr:partnerContribution>Analytical support (Dave Smith) and entomological studies (Janet Midega)</gtr:partnerContribution><gtr:piContribution>Analysis of spatial field entomology data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Multi-centre spatial epidemiology</gtr:description><gtr:id>21790AAC-FD06-42C4-8B9F-41EFC662147F</gtr:id><gtr:impact>Paper in preparation</gtr:impact><gtr:outcomeId>ocmiMnb5nfv-1</gtr:outcomeId><gtr:partnerContribution>Providing data.</gtr:partnerContribution><gtr:piContribution>Assembling data for multi-centre analysis and analysis plan.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>MVVC</gtr:description><gtr:id>B599AD63-C6F7-4350-A9AB-731BE2E0C7B5</gtr:id><gtr:impact>Publications on Phase 1 trials, Phase 2 trials in progress</gtr:impact><gtr:outcomeId>PGrZKWHrePG-1</gtr:outcomeId><gtr:partnerContribution>Supply of vaccines and clinical testing in other sites</gtr:partnerContribution><gtr:piContribution>Clinical testing of vaccine candidates</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kenyan Institute for Medical Research (KEMRI)</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI/CDC Research and Public Health Collaboration</gtr:department><gtr:description>Multi-centre hotspots</gtr:description><gtr:id>8B3FE208-1920-4D73-B5B4-0C54BB017063</gtr:id><gtr:impact>A pooled analysis of data has been completed and submitted for publication.</gtr:impact><gtr:outcomeId>58b80f72505156.04123765-5</gtr:outcomeId><gtr:partnerContribution>Sharing of data in order to support a pooled analysis of hotspots in multiple datasets. Submitted for publication.</gtr:partnerContribution><gtr:piContribution>Analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio Programme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>194FC456-382A-49DB-AF1A-19804C37D572</gtr:id><gtr:impact>I discussed malaria research in an interview and call-in radio programme.</gtr:impact><gtr:outcomeId>58468eb5551e13.65091035</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://barakafm.org/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Writing leaflets and material for public engagement</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0638C411-4EEC-481E-AB58-48590A378610</gtr:id><gtr:impact>Part of a local &amp;quot;show&amp;quot; including organizations based in the area.</gtr:impact><gtr:outcomeId>56daa971af3650.82428299</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Community Liaison Meetings in Kenya</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>58F5C2FF-6999-4399-B8DA-2B3C100BE67B</gtr:id><gtr:impact>A series of meetings have been held in the research programme taking 100 community representatives at a time and describing individual research studies with a question and answer session.

Recruitment to further studies has been facilitated and communication regarding our research in the field is easier.</gtr:impact><gtr:outcomeId>XGyLLB4rm3a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Strategic Award</gtr:department><gtr:description>Strategic Award</gtr:description><gtr:end>2020-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>208581A4-5E1C-4391-BE8E-AFBC2E73BFFF</gtr:id><gtr:outcomeId>56d998f13f9335.91533123</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>895946</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Technology Assessment</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>B13AA785-751A-461A-AEF2-F8CE4A432034</gtr:id><gtr:outcomeId>GuMXUHzWzvi</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1101415</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>Strategic Primer Grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>B29F4407-0DED-4436-A2A6-822281B65D1A</gtr:id><gtr:outcomeId>q2hizn2HxT7</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advise WHO working group on transmission dynamics of malaria</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0F6F4C62-13B1-4B18-A427-2DD48FDF3068</gtr:id><gtr:outcomeId>tSE8jcFd7Bb</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Transmission measures working group, Malaria Vaccine Initiative</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>B7B4809F-F157-490D-9A01-E363AD70C1A2</gtr:id><gtr:outcomeId>qmTBv347rfW</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advise Technical Advisory Group to WHO</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>64DD60A4-28EF-4071-9491-4FAA5CF78EE1</gtr:id><gtr:impact>Advice to committee regarding recommendations for vaccine pre-qualification</gtr:impact><gtr:outcomeId>FVuMfEKSTsW</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EB0A5403-F95E-4D91-9D01-85D7D1AAC7FD</gtr:id><gtr:title>Effect of transmission intensity on hotspots and micro-epidemiology of malaria in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57a4abdda25b92c3b33dd7b84605f0a7"><gtr:id>57a4abdda25b92c3b33dd7b84605f0a7</gtr:id><gtr:otherNames>Mogeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>5aa0ca461a9877.59663589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB3CFD64-F0DC-4DD6-A4D1-55708611F890</gtr:id><gtr:title>Geographic-genetic analysis ofparasite populations from surveys of primary school children in Western Kenya.</gtr:title><gtr:parentPublicationTitle>Wellcome open research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/800fd4291cab99ab5fab2e2deec3c676"><gtr:id>800fd4291cab99ab5fab2e2deec3c676</gtr:id><gtr:otherNames>Omedo I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2398-502X</gtr:issn><gtr:outcomeId>5a3518bea11128.42871121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EF23726-F5CC-4FB1-BEEA-3343CDB7D549</gtr:id><gtr:title>Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57a4abdda25b92c3b33dd7b84605f0a7"><gtr:id>57a4abdda25b92c3b33dd7b84605f0a7</gtr:id><gtr:otherNames>Mogeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5aa0ca45e36fc0.97657855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D83F516-3058-4E9F-9D5B-2E3DBF91AE69</gtr:id><gtr:title>Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2712410327b340c558afe848b2fd2e39"><gtr:id>2712410327b340c558afe848b2fd2e39</gtr:id><gtr:otherNames>Kangoye DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58468b3ec31ad4.32207045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C9A69F8-34F5-4CAE-A40C-2802F275B9B8</gtr:id><gtr:title>A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine againstAdministered Intramuscularly to Adults from a Shigellosis-Endemic Country.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c19d6f67754b3b9c4f2d9bb5f07538e4"><gtr:id>c19d6f67754b3b9c4f2d9bb5f07538e4</gtr:id><gtr:otherNames>Obiero CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5aa0ca443a76c5.84528805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49D7781A-F49A-46FF-895A-5080B970A477</gtr:id><gtr:title>Trends in bednet ownership and usage, and the effect of bednets on malaria hospitalization in the Kilifi Health and Demographic Surveillance System (KHDSS): 2008-2015.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf76eb54857b80727fe9ba8ab00381e"><gtr:id>ddf76eb54857b80727fe9ba8ab00381e</gtr:id><gtr:otherNames>Kamau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5aa0ca452e3797.93278554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76D7C9D9-C872-4AC6-847C-93239506A7DA</gtr:id><gtr:title>The relationship between RTS,S vaccine-induced antibodies, CD4? T cell responses and protection against Plasmodium falciparum infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_23613845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C6A7582-D36E-4CE1-84EE-D13EFA9C62CB</gtr:id><gtr:title>Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2b62a290440e075f136b8aac316bc22"><gtr:id>e2b62a290440e075f136b8aac316bc22</gtr:id><gtr:otherNames>Illingworth J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14141_21_23264654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F942BDA-3A0A-49C4-9ADF-9F17EFA0C69B</gtr:id><gtr:title>Estimating individual exposure to malaria using local prevalence of malaria infection in the field.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8f5cf5efad6f6aa332e67f05b9434c"><gtr:id>0c8f5cf5efad6f6aa332e67f05b9434c</gtr:id><gtr:otherNames>Olotu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_22479349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBBF55F3-AC17-498A-8DD3-237F6663D499</gtr:id><gtr:title>Proteomic analysis of extracellular vesicles from aKenyan clinical isolate defines a core parasite secretome.</gtr:title><gtr:parentPublicationTitle>Wellcome open research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12ef6a604533c1230b8cefd93cdbaf5"><gtr:id>a12ef6a604533c1230b8cefd93cdbaf5</gtr:id><gtr:otherNames>Abdi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2398-502X</gtr:issn><gtr:outcomeId>5aa0c99373d283.43849368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE222FED-056C-4244-8E60-6304B476BAAB</gtr:id><gtr:title>Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97e5f6c4ccbeb69001b48f883691b89d"><gtr:id>97e5f6c4ccbeb69001b48f883691b89d</gtr:id><gtr:otherNames>Gon?alves BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aa0ca45502ae7.59491495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>057AC65E-7E4F-4002-AEB3-4E1831B3240E</gtr:id><gtr:title>The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological &amp;quot;natural experiment&amp;quot;.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b5f775dbe1ff55e47dbc33618065021"><gtr:id>7b5f775dbe1ff55e47dbc33618065021</gtr:id><gtr:otherNames>Bediako Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>58468b3d6cd071.05618735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84CA16F4-1303-430E-A558-60ADED78458A</gtr:id><gtr:title>Genetic diversity of the African malaria vector Anopheles gambiae.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27270c0e4754e0bdf2e6597a3aa5de20"><gtr:id>27270c0e4754e0bdf2e6597a3aa5de20</gtr:id><gtr:otherNames>Anopheles gambiae 1000 Genomes Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa0ca45033e02.54620414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A962B4D-0363-493C-B6AA-45DC9CCE55B2</gtr:id><gtr:title>Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e9f161d0d5724a4e59753ed3f3be8de"><gtr:id>7e9f161d0d5724a4e59753ed3f3be8de</gtr:id><gtr:otherNames>Ogwang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>56d99613c2a174.38385526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5AD3687-BD20-4B9E-AA2E-CCCFE91EC0C4</gtr:id><gtr:title>Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/539a8e7d7c849ce0ace22cd2b7c6cdba"><gtr:id>539a8e7d7c849ce0ace22cd2b7c6cdba</gtr:id><gtr:otherNames>Ochola-Oyier LI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58468b3de25f83.37924700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D6EE24D-2D86-405E-A36F-E7E5D587AEDA</gtr:id><gtr:title>Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57a4abdda25b92c3b33dd7b84605f0a7"><gtr:id>57a4abdda25b92c3b33dd7b84605f0a7</gtr:id><gtr:otherNames>Mogeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58468b3db7c3e6.20576458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A331DAC0-1235-4805-8798-E686439EA122</gtr:id><gtr:title>Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bd0b08c7569d3fbb892d3070c540098"><gtr:id>5bd0b08c7569d3fbb892d3070c540098</gtr:id><gtr:otherNames>Afolabi MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>58468b3e0f5622.18664951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5452A646-5E98-4F79-95BD-3BAFD6764A84</gtr:id><gtr:title>Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54817bccf0cc7f30db605bb92b765d2c"><gtr:id>54817bccf0cc7f30db605bb92b765d2c</gtr:id><gtr:otherNames>Horowitz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14141_21_22504653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84DC0769-D734-4BCC-9326-D25F1AA1C2F7</gtr:id><gtr:title>Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e9f161d0d5724a4e59753ed3f3be8de"><gtr:id>7e9f161d0d5724a4e59753ed3f3be8de</gtr:id><gtr:otherNames>Ogwang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_23526949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>822384D7-AC5F-4567-8F15-8300053BBD9A</gtr:id><gtr:title>Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2712410327b340c558afe848b2fd2e39"><gtr:id>2712410327b340c558afe848b2fd2e39</gtr:id><gtr:otherNames>Kangoye DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464bdb5c77869.09001955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E48E21-1AA1-4481-AFF6-5A39A28F61E0</gtr:id><gtr:title>A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9b36f58c5a1712335213202743d2d88"><gtr:id>a9b36f58c5a1712335213202743d2d88</gtr:id><gtr:otherNames>Ndungu FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_23300801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78D0DAA9-2CBB-4497-95E2-015B5A8665ED</gtr:id><gtr:title>Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9b36f58c5a1712335213202743d2d88"><gtr:id>a9b36f58c5a1712335213202743d2d88</gtr:id><gtr:otherNames>Ndungu FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>56d99614563b96.71218303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>031307D3-4C45-4BC9-9D1E-E8881648E4E5</gtr:id><gtr:title>Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2712410327b340c558afe848b2fd2e39"><gtr:id>2712410327b340c558afe848b2fd2e39</gtr:id><gtr:otherNames>Kangoye DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56d99614d583f3.87131462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>967682E9-8A34-400E-8FA9-60C7D7122F37</gtr:id><gtr:title>Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8f5cf5efad6f6aa332e67f05b9434c"><gtr:id>0c8f5cf5efad6f6aa332e67f05b9434c</gtr:id><gtr:otherNames>Olotu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_14141_21_23514288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB99AC90-7872-4D6F-BC18-1E2FA9841451</gtr:id><gtr:title>Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a65259c0b4f15be65eecfe8ce12e772"><gtr:id>7a65259c0b4f15be65eecfe8ce12e772</gtr:id><gtr:otherNames>Hodgson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d99613849391.89355285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21F83746-F035-4FCC-8B03-87CDE9A3B5C5</gtr:id><gtr:title>Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d727e8606fb5453078c634a9cf265935"><gtr:id>d727e8606fb5453078c634a9cf265935</gtr:id><gtr:otherNames>Warimwe GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>pm_14141_21_23962071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12B190E7-CADB-4E4F-AE6E-443DA88CB1E6</gtr:id><gtr:title>Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8f5cf5efad6f6aa332e67f05b9434c"><gtr:id>0c8f5cf5efad6f6aa332e67f05b9434c</gtr:id><gtr:otherNames>Olotu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f985985a1ad976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>252B166D-CA8C-42F1-8C10-7A9F041A5018</gtr:id><gtr:title>The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial</gtr:title><gtr:parentPublicationTitle>The Lancet Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52d67f6b6f6ed11374713c84c72a44f3"><gtr:id>52d67f6b6f6ed11374713c84c72a44f3</gtr:id><gtr:otherNames>Huttner A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d9961436bbd7.13467896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD83C21-A894-43E4-ADB2-D6C75BB719A7</gtr:id><gtr:title>A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/976d70ab75b4bb0a47e4714464720429"><gtr:id>976d70ab75b4bb0a47e4714464720429</gtr:id><gtr:otherNames>Tan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d996152a0552.91626725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C697588-32DF-43A9-9A36-EFE9381C0EE1</gtr:id><gtr:title>Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87b7ade1635f3a43321027d8297a699e"><gtr:id>87b7ade1635f3a43321027d8297a699e</gtr:id><gtr:otherNames>Snow RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d9961418bd94.43074417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB16EFB6-825F-4E76-A1F2-5775571593A8</gtr:id><gtr:title>A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/080d9c77d9089737ba36e6a808316bf7"><gtr:id>080d9c77d9089737ba36e6a808316bf7</gtr:id><gtr:otherNames>Bejon P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a2fd8a8409b46.63706792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18E53AFF-3015-4996-AB33-3EBCC2ED6487</gtr:id><gtr:title>Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/080d9c77d9089737ba36e6a808316bf7"><gtr:id>080d9c77d9089737ba36e6a808316bf7</gtr:id><gtr:otherNames>Bejon P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>pm_14141_21_23454164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA0D852-D796-4FA0-A47D-4759296C486F</gtr:id><gtr:title>Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn><gtr:outcomeId>56d99614f154d1.62094718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A178F7-C16A-43A2-9A3B-AFD8D0FF28A5</gtr:id><gtr:title>Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d522e570384bb31e07c84d7a03b790"><gtr:id>e4d522e570384bb31e07c84d7a03b790</gtr:id><gtr:otherNames>White M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d9961476d256.34823841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7013D173-F52F-4881-A640-65C545DB94FD</gtr:id><gtr:title>A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9a033b63cce50354d377a5446bae3bd"><gtr:id>b9a033b63cce50354d377a5446bae3bd</gtr:id><gtr:otherNames>Murungi LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_14141_21_23800539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54A658DB-B2A7-4EF8-BE47-BB9BC343080D</gtr:id><gtr:title>A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f56584c638d4ce39ec15347d619b6f1"><gtr:id>8f56584c638d4ce39ec15347d619b6f1</gtr:id><gtr:otherNames>White MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>5464bdb6230fa3.49705967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2772D607-EF65-4026-A266-20DD495C742C</gtr:id><gtr:title>A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50bd36c841b67fa5fd235c13e265c140"><gtr:id>50bd36c841b67fa5fd235c13e265c140</gtr:id><gtr:otherNames>Wendler JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_24809681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F8F1EAA-3CF9-4FC3-95FE-C87CDA41EBDB</gtr:id><gtr:title>The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87b7ade1635f3a43321027d8297a699e"><gtr:id>87b7ade1635f3a43321027d8297a699e</gtr:id><gtr:otherNames>Snow RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa0ca456f0437.85087699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C7E2E07-5F41-4376-8A0A-9D038B338627</gtr:id><gtr:title>Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8f5cf5efad6f6aa332e67f05b9434c"><gtr:id>0c8f5cf5efad6f6aa332e67f05b9434c</gtr:id><gtr:otherNames>Olotu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58468b3d99b174.18682568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4CCCB19-0A94-4D9C-99AB-4886EB5D58B9</gtr:id><gtr:title>Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7218a4a1ad49fafb16d3dca619853770"><gtr:id>7218a4a1ad49fafb16d3dca619853770</gtr:id><gtr:otherNames>Ibison F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_23300828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67A110F6-ED38-40A1-B734-89EB438E2338</gtr:id><gtr:title>Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e67f34502427a5b0a697e2936db987c"><gtr:id>8e67f34502427a5b0a697e2936db987c</gtr:id><gtr:otherNames>Midega JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_14141_21_22334077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C99EE124-3DBF-4100-9096-308B1E779C60</gtr:id><gtr:title>The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d727e8606fb5453078c634a9cf265935"><gtr:id>d727e8606fb5453078c634a9cf265935</gtr:id><gtr:otherNames>Warimwe GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14141_21_23437368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>801E8D69-1EAE-433B-B749-8AAE9981ECCC</gtr:id><gtr:title>Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c14f468562fffaa13dd59e4fc7fddc23"><gtr:id>c14f468562fffaa13dd59e4fc7fddc23</gtr:id><gtr:otherNames>Douglas AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_14141_21_23570846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57DE1938-857F-4837-8AC7-587E7CB6C1A9</gtr:id><gtr:title>Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75fe81f3f270ea539ca04e73cdd58c34"><gtr:id>75fe81f3f270ea539ca04e73cdd58c34</gtr:id><gtr:otherNames>RTS,S Clinical Trials Partnership</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5464bdb5ee5be0.45615732</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002624</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>